JPMORGAN CHASE & CO - AIMMUNE THERAPEUTICS INC ownership

Back to all holdings Add to watchlist

AIMMUNE THERAPEUTICS INC's ticker is and the CUSIP is 00900T957. A total of 3 filers reported holding AIMMUNE THERAPEUTICS INC in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.0%.

Links
Filings
Quarter-by-quarter ownership
JPMORGAN CHASE & CO ownership history of AIMMUNE THERAPEUTICS INC
ValueSharesWeighting
Q3 2019$419,000
-39.9%
20,000
-42.9%
0.00%–
Q2 2019$697,000
-78.9%
35,000
-76.3%
0.00%
-100.0%
Q1 2019$3,306,000
+591.6%
147,900
+639.5%
0.00%–
Q4 2018$478,000
-58.3%
20,000
-44.4%
0.00%–
Q1 2018$1,146,000–36,000–0.00%–
 Download
Other shareholders

There were no reported owners of AIMMUNE THERAPEUTICS INC in Q4 2019.

NameSharesValueWeighting ↓
View complete list of AIMMUNE THERAPEUTICS INC shareholders